November 1, 2011
Mochida Pharmaceutical reported sales of ¥42,512 million (+8.6% over the corresponding period of the previous year) in its consolidated settlement of accounts for April-September 2011. The company’s good performance was driven by growth in sales of the major hyperlipidemia and...read more